XLON
AGR
Market cap2.03bUSD
Oct 03, Last price
47.48GBP
Name
Assura PLC
Chart & performance
P/E
9.30
P/S
8.40
EPS
0.05
Div yield, %
5.27%
Shrs. gr., 5y
5.57%
Rev. gr., 5y
10.51%
Revenues
184m
+16.48%
Net income
166m
P
CFO
111m
+7.91%
Dividend
Aug 14, 20250.84 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Assura plc, a prominent entity within both the FTSE 250 and EPRA indices, operates as a UK Real Estate Investment Trust (REIT). The company specializes in the long-term investment and development of properties dedicated to primary healthcare. Based in Warrington, Assura collaborates closely with GPs, other health professionals, and the National Health Service (NHS) to provide high-quality environments for health service delivery in communities across the UK. By 30 September 2020, the total value of Assura's property holdings amounted to £2,259 million.
Key people
Ed Smith
Non-Executive Chairman of the Board · since 2018
Jonathan Stewart Murphy
Chief Executive Officer, Executive Director · since 2017
Jayne Cottam
Chief Financial Officer, Executive Director · since 2017
Orla Ball
Company Secretary · since 2016
Non-Executive Director · since 2018
Non-Executive Director · since 2019
Non-Executive Independent Director · since 2012
David H. Richardson
Senior Non-Executive Independent Director · since 2012
Headquarters & legal address
3 BARRINGTON ROAD
ALTRINCHAM, MAN WA14 1GY
GB
ALTRINCHAM, MAN WA14 1GY
GB
Previous name
ASSURA PLC
Previous name
ASSURA KINGSTON PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||